Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction

NCT04884243 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Meibomian Gland Dysfunction

Interventions

DRUG: CBT-006

Sponsor

Cloudbreak Therapeutics, LLC